Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients.

Ji Young YouKyoung Hwa ParkEun Sook LeeYoungmee KwonKyoung Tae KimSeungyoon NamDong Hee KimJeoung Won Bae

Published in: Cancer control : journal of the Moffitt Cancer Center (2023)

This multigene assay-based study provides insights into breast cancer signaling and possible predictions of therapeutic response to targeted therapies such as trastuzumab.

Keyphrases

positive breast cancer
end stage renal disease
ejection fraction
prognostic factors
stem cells
epidermal growth factor receptor
bone marrow
cell therapy
patient reported
single cell
metastatic breast cancer